T 0802/13 () of 19.3.2018 | XEPC: EPC and PCT resource

European Case Law Identifier:

ECLI:EP:BA:2018:T080213.20180319

Date of decision:

19 March 2018

Case number:

T 0802/13

Application number:

05796880.2

IPC class:

A61M 5/145
A61M 5/315

Language of proceedings:

Distribution:

Download and more information:

Decision text in EN (PDF, 515Â KB)
Documentation of the appeal procedure can be found in the Register
Bibliographic information is available in:	EN
Versions:	Unpublished

Title of application:

INJECTION DEVICE WITH TORSION SPRING AND ROTATABLE DISPLAY

Applicant name:

Novo Nordisk A/S

Opponent name:

Genentech, Inc.
COPERNICUS sp. zo.o.
Ferring International Center S.A.
OWEN MUMFORD LIMITED
Ypsomed AG
StÃ¶ckeler, Ferdinand

Board:

3.2.02

Headnote:

Relevant legal provisions:

European Patent Convention Art 123(2)
European Patent Convention R 115(2)
Rules of procedure of the Boards of Appeal Art 15(3)
European Patent Convention Art 111(1)

Keywords:

Oral proceedings - held in absence of two parties
Amendments - intermediate generalisation added subject-matter (no)
Appeal decision - remittal to the department of first instance (yes)

Catchwords:

Cited decisions:

G 0003/89
G 0011/91
G 0002/10
T 1067/97
T 0714/00
T 1906/11

Citing decisions:

T 2177/15

Source: http://www.epo.org/law-practice/case-law-appeals/recent/t130802eu1.html

Date retrieved: 17 May 2021